(2026). Serum Midkine as a Biomarker for Hepatocellular Carcinoma Treatment Response and Prognostication. Journal of Clinical Laboratory Analysis.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Serum Midkine as a Biomarker for Hepatocellular Carcinoma Treatment Response and Prognostication."
Journal of Clinical Laboratory Analysis 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Serum Midkine as a Biomarker for Hepatocellular Carcinoma Treatment Response and Prognostication."
Journal of Clinical Laboratory Analysis, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.